185 related articles for article (PubMed ID: 17017677)
1. Clinical and translational advances in ovarian cancer therapy.
Konstantinopoulos PA; Matulonis UA
Nat Cancer; 2023 Sep; 4(9):1239-1257. PubMed ID: 37653142
[TBL] [Abstract][Full Text] [Related]
2. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer.
Liu Z; Jing C; Kong F
J Ovarian Res; 2024 Feb; 17(1):39. PubMed ID: 38347608
[TBL] [Abstract][Full Text] [Related]
3. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements.
Tavares V; Marques IS; Melo IG; Assis J; Pereira D; Medeiros R
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339123
[TBL] [Abstract][Full Text] [Related]
4. Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.
O'Dwyer J; O'Cearbhaill RE; Wylie R; O'Mahony S; O'Dwyer M; Duffy GP; Dolan EB
Adv Ther (Weinh); 2020 Nov; 3(11):. PubMed ID: 33709016
[TBL] [Abstract][Full Text] [Related]
5. Update on first-line treatment of advanced ovarian carcinoma.
Kemp Z; Ledermann J
Int J Womens Health; 2013; 5():45-51. PubMed ID: 23378788
[TBL] [Abstract][Full Text] [Related]
6. Unlocking the 'ova'-coming power: immunotherapy's role in shaping the future of ovarian cancer treatment.
Haines NA; Fowler MG; Zeh BG; Kriete CB; Bai Q; Wakefield MR; Fang Y
Med Oncol; 2024 Jan; 41(3):67. PubMed ID: 38286890
[TBL] [Abstract][Full Text] [Related]
7. Rare ovarian tumours. Other treatments for ovarian cancer.
Gil-Martin M; Pardo B; Barretina-Ginesta MP
EJC Suppl; 2020 Aug; 15():96-103. PubMed ID: 33240448
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of epithelial ovarian cancer].
Langmár Z; Csömör S
Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
10. Medical treatment of epithelial ovarian cancer.
González-Martín AJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of ovarian cancer].
Cianti C
Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
[TBL] [Abstract][Full Text] [Related]
12. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF
Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
du Bois A; Lück HJ; Meerpohl HG
Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
